SCHEMBL6380656

SCHEMBL6380656

CCCCCCCOC[C@H]1OC(OC(C)C)[C@H](OC)[C@@H](OCCC)[C@@H]1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 1/20 0.46
▸ GJB2 P29033 4/20 0.41
▸ GBA1 P04062 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ SSTR1 P30872 1/20 0.35
▸ SSTR2 P30874 1/20 0.35
▸ SSTR4 P31391 1/20 0.35
▸ SSTR3 P32745 1/20 0.35
▸ SSTR5 P35346 1/20 0.35
▸ SPHK2 Q9NRA0 1/20 0.34
▸ SPHK1 Q9NYA1 1/20 0.34
▸ USP2 O75604 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ AKT1 P31749 2/20 0.33
▸ PLCG2 P16885 1/20 0.33
▸ PIK3R1 P27986 1/20 0.33
▸ AKT2 P31751 1/20 0.33
▸ PIK3CA P42336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6380820 0.89 TNF (0.56) TNFGJB2GBA1ALDH1A1TDP1
SCHEMBL6380615 0.86 TNF (0.60) TNFGJB2GBA1ALDH1A1TDP1
SCHEMBL6383580 0.85 TNF (0.46) TNFGJB2GBA1MAPK1
SCHEMBL6380648 0.80 TNF (0.50) TNFGJB2GBA1ALDH1A1TDP1
SCHEMBL6384903 0.79 TNF (0.55) TNFGJB2GBA1MAPK1
SCHEMBL6383996 0.77 TNF (0.37) TNFGJB2GBA1SSTR1SSTR2
SCHEMBL28296339 0.77 GBA1 (0.51) TNFGJB2GBA1MAPK1
SCHEMBL12777881 0.76 TNF (0.57) TNFGJB2GBA1SSTR1SSTR2
SCHEMBL14417482 0.76 TNF (0.57) TNFGJB2GBA1SSTR1SSTR2
SCHEMBL14302426 0.76 TNF (0.57) TNFGJB2GBA1SSTR1SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001961-B1 SUBSTITUTED TETRAHYDROPYRANE DERIVATIVES AND METHOD FOR PRODUCING SAME AVENTIS PHARMA GMBH (DE) 2005-01-26 — — EP disclosed
US-6756489-B1 PROTECTED MONOSACCHARIDES HAVING AN ALLYL PROTECTING GROUP, A SILANE-PROTECTED HYDROXY GROUP AND A CARBOXY OR AMIDE CONTAINING PROTECTIVE GROUP; EASILY MADE BY COMBINATORIAL CHEMISTRY; APPLICATIONS TO AUTOIMMUNE AND CANCER AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-06-29 — — US disclosed
Send feedback